Bhaswanth Dhanireddy, MD
Radiation Oncology · Shawnee Mission, KSNPI 1679972467
Payments from drug & device makers
What this record shows
25 manufacturers reported payments, led by Viewray Technologies Inc at 56.5% of the total. Reporting peaked in 2022 at $1,783 and has fallen 96.0% since, to $71 in 2025.
Across 38 payments — averaging $71.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viewray Technologies Inc$2K
- Elekta, Inc.$319
- Isoray, Inc$200
- Bioprotect Medical, Inc.$118
- Zap Surgical Systems, Inc.$68
- Coherus Oncology, Inc.$47
- plus $429 from 19 others
What the payments were for
- Travel & lodging$1,21245%
- Food & beverage$1,50155%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viewray Technologies Inc | 6 | $1,532 |
| Elekta, Inc. | 4 | $319 |
| Isoray, Inc | 2 | $200 |
| Bioprotect Medical, Inc. | 1 | $118 |
| Zap Surgical Systems, Inc. | 1 | $68 |
| Coherus Oncology, Inc. | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $47 |
| Tersera Therapeutics LLC | 1 | $47 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Novocure Inc. | 2 | $34 |
| Myovant Sciences Inc. | 1 | $28 |
| Merck | 1 | $24 |
| Gilead | 1 | $20 |
| AMAG Pharmaceuticals, Inc. | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $17 |
| Incyte Corporation | 1 | $17 |
| Sanofi | 1 | $17 |
| AstraZeneca | 1 | $15 |
| Amgen | 1 | $15 |
| Novartis | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Kyowa Kirin, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MRIdian LINAC$1,212
- MRIdian$150
- ELEKTA UNITY$147
- BIOPROTECT BALLOON IMPLANT SYSTEM$118
- Brachytherapy Source$114
How this compares
$2,713 in reported general payments places this provider in the 70th percentile of 54 radiation oncology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SsdSilver Sulfadiazine | 12 | $104 |
| Ondansetron Hcl | 13 | $83 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Shawnee Mission
- Ronald ChenKansas City$31K
- Xinglei ShenKansas City$16K
- David BryantWichita$15K
- Mark ThompsonOverland Park$9K
- David AkhavanKansas City$9K
- Fen WangKansas City$7K
- Joshua WeirWichita$6K
- Vickie MasseyOverland Park$5K
- Gregory GanKansas City$5K
- Ronny RotondoKansas City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.